Genetic screens for dominant second-site mutations that suppress the lethality of Abl mutations in Drosophila identified alleles of only one gene, enabled (ena). We report that the ena protein contains proline-rich motifs and binds to Abl and Src SH3 domains, ena is also a substrate for the Abl kinase; tyrosine phosphorylation of ena is increased when it is coexpressed in cells with human or Drosophila Abl and endogenous ena tyrosine phosphorylation is reduced in Abl mutant animals. Like Abl, ena is expressed at highest levels in the axons of the embryonic nervous system and ena mutant embryos have defects in axonal architecture. We conclude that a critical function of Drosophila Abl is to phosphorylate and negatively regulate ena protein during neural development.
The Abelson family of nonreceptor protein-tyrosine kinases (PTKs) consists of the mammalian c-abl and c-arg genes, Drosophila Abl and caenorhabditis elegans Abl (Wang 1993) . The proteins have well-conserved SH3, SH2, and kinase catalytic domains and are distinguished from the src family of nonreceptor tyrosine kinases by a large (-600-amino-acid) domain carboxy-terminal to the kinase domain. Several functions have been attributed to this carboxy-terminal region including nuclear localization (Van Etten et al. 1989) , DNA binding (Kipreos and Wang 1992) , F-actin and G-actin binding ), SH3-domain binding (Feller et al. 1994; Ren et al. 1994) , and, in Drosophila, localization of the protein to axonal processes in the developing nervous system (Henkemeyer et al. 1988) . Mammalian c-Abl displays both cytoplasmic and nuclear localization (Van Etten et al. 1989; Wang 1993) in fibroblasts, although it is reported to be primarily cytoplasmic in hematopoietic cells (Wetzler et al. 1994) . RNA polymerase II (Baskaran et al. 1993) and the c-crk adapter protein (Feller et al. 1994; Ren et al. 1994) have been reported to be substrates for the c-Abl PTK, and recent studies have identified asso- ciations between c-Abl and crk (Feller et al. 1994; Ren et al. 1994 ) and between c-Abl and Rb (Welch and Wang 1993) . However, it is as yet unclear how important these interactions are for Abl-mediated signaling.
Much of the interest in the Abl PTK stems from the involvement of oncogenically activated derivatives of the c-Abl PTK in Philadelphia chromosome-positive chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) in humans and the pre-B-cell leukemia caused by Abelson murine leukemia virus in mice. The Philadelphia chromosome translocations generate fusions between the c-abl and bcr genes (Shtivelman et al. 1985; Ben-Neriah and Baltimore 1986) . The chimeric protein products of these oncogenes exhibit elevated tyrosine kinase activity (Kloetzer et al. 1985; Konopka et al. 1985) , oligomerization and association with the actin cytoskeleton (McWhirter and Wang 1991, 1993) , tyrosine phosphorylation of Bcr sequences (Liu et al. 1993) , and association with GRB2 (Pendergast et al. 1993; Puil et al. 1994) , Shc (Matsuguchi et al. 1994; Puil et al. 1994) , cbl (Andoniou et al. 1994) , Syp (Tauchi et al. 1994) , and members of the 14-3-3 protein family (Reuther et al. 1994) .
The function of c-Abl in mammalian development is as yet unclear. Recent studies suggest that c-Abl in the nucleus can negatively regulate proliferation of fibroblasts in culture (Sawyers et al. 1994) . Targeted disruptions of c-abl in the mouse causes perinatal lethality with no obvious phenotypic abnormalities (Schwartzberg et al. 1991; Tybulewicz et al. 1991) . Null mutations in Drosophila also cause late lethality after development of the adult fly during metamorphosis (Henkemeyer et al. 1987) . The observation that loss of Drosophila Abl function does not result in more severe defects earlier in development suggests that the absence of Abl function can be partially compensated for by redundant functions (Hoffmann 1991) .
Screens for second-site mutations that interact genetically with Abl in flies have identified mutations in three genes [disabled (dab), prospero (pros) , or failed axon connections (fax)] whose products are in part responsible for masking the function of Drosophila Abl. Whereas AbI mutant animals die at the end of pupation, flies that lack Abl function and have only one copy of dab, fax, or pros die during embryonic or larval stages (Gertler et al. 1989 (Gertler et al. , 1993 . When mutations are used to remove these functionally redundant proteins, the roles of the Abl PTK in axonogenesis of the embryonic central nervous system (CNS) and in the formation of muscle attachment sites are revealed. For example, Abl mutant embryos that also lack dab display defects in the axonal architecture of the embryonic CNS and in body wall muscle attachments (Gertler et al. 1989 (Gertler et al. , 1993 Bennett and Hoffmann 1992) . Presumably, similar mechanisms of functional redundancy mask more severe effects of the c-abl null mutations in the mouse.
To gain further insight into the normal functions of a member of the Abl PTK family, we have screened for second-site modifier mutations that suppress the lethality of Abl mutations in Drosophila. We have recovered mutations in only one gene, which we have named enabled (ena). Although Abl mutant animals die at the end of pupation or as young adults, flies that lack Abl function and have only one copy of the ena gene survive to adulthood with no obvious defects . Heterozygous ena mutations also largely restore normal axonal patterning in embryos mutant for Abl and dab. . The observation that a reduction in the level of ena compensates for the absence of Abl activity suggests that these two molecules normally function in opposition to one another in a precise balance.
We have cloned the ena gene and report that it encodes a novel protein with several proline-rich SH3 binding motifs. Bacterially expressed ena protein is bound by the GST-AblSH3 and GST-SrcSH3 proteins in filter-binding assays but not by several other GST-SH3 domain fusion proteins. The ena protein contains phosphotyrosine in vivo and is phosphorylated by the Drosophila or human Abl PTK when coexpressed in Drosophila cultured cells. Of particular interest is the observation that the level of phosphotyrosine on endogenously expressed ena is reduced in Abi mutant animals. As would be consistent for an in vivo Abl substrate, ena protein is colocalized with Abl in the axons of the embryonic CNS. Mutations in ena cause defects in the axonal architecture of the CNS and peripheral nervous system (PNS) including misrouted axons and loosely packed bundles of axons. On the basis of these genetic and biochemical properties, we propose that phosphorylation of ena by Abl regulates the function of ena during axonogenesis and that this is a key physiological role of the Abl PTK in Drosophila.
Results

Molecular cloning of ena and sequence analysis
Previous studies had mapped ena to the 55F-57A region of the Drosophila chromosomes (Gertler et al. 1989 . To localize the gene more precisely, ~-rays were used to induce cytologically visible chromosomal aberrations in the ena locus. Nine new ena alleles were recovered in this screen, and five of these mutations caused visible rearrangements that affected 56B5 (Fig.  1A) . We obtained a P-element insertion at this location from Dr. Gerald M. Rubin (University of California, Berkeley), and flanking genomic DNA was recovered by plasmid rescue. The rescued fragment was used to begin a chromosome walk in which 54 kb of DNA from the 56B region was isolated (Fig. 1A) . Chromosomal rearrangements in ena mutants were identified with probes from the walk, with three inversion and one translocation breakpoints all recognized by a single 5.5-kb probe (Fig. 1A, fragment A) . This 5.5-kb fragment was used to isolate cDNAs from an embryonic cDNA library (Brown and Kafatos 1988) , the longest of which was 3.4 kb. Southern analyses showed that the eDNA spanned the same rearrangement breakpoints mapped on the walk (data not shown), indicating that the 3.4-kb cDNA represented the ena transcript.
The lethality caused by ena mutations was prevented by expression of this cDNA in the CNS of developing ena mutants, confirming that this cDNA is the product of the ena gene. This was accomplished using the GAL4 binary expression system (Brand and Perrimon 1993) . Several transgenic lines were recovered of independent insertions of a P-element transgene in which the ena cDNA was expressed under the control of the yeast GAL4 upstream activating sequence (UAS). Flies from these different transgenic lines of P[UAS-ena, w + ] were mated to flies expressing GAL4 in all neuronal cells. The GAL4 expression was the result of an enhancer-trap insertion of a GAL4-encoding P-element transgene (a gift of Dr. Andrea Brand, Wellcome/CRC Institute, Cambridge, UK). Progeny in which the endogenous ena gene was mutant died unless they inherited both the P[UASena, w + ] transgene and the GAL4 transgene. The neuralspecific expression of ena from the transgene allowed 60% of the expected progeny class to survive as fertile flies without detectable phenotypic abnormalities (not shown). Although the lethal phase of the other 40% of the progeny class is not known, the incomplete rescue may be attributable to differences between endogenous expression levels or patterns and those generated by the GAL4 binary expression system.
Sequencing of the ena cDNA revealed an open reading flame of 684 amino acids with a predicted molecular mass of 72 kD (Fig. 1B) . Searches of the GenEMBL and ( 1' ) The insertion site of a P element (AA48). This transposon was used to recover 7 kb of genomic DNA (horizontal arrow) that was used to initiate a chromosomal walk. Stippled regions hybridized to ena cDNA probes. Brackets beneath the diagram indicate the positions of deletion and rearrangement breakpoints associated with 7-ray-induced ena mutations. Probe A is a 5.5-kb DNA fragment that detected rearrangement breakpoints in ena alleles and was used to screen the cDNA library. (B) Predicted amino acid sequence of the ena protein.
The 684-amino-acid sequence encoded by the ena cDNA is shown. Underlined are seven matches to a consensus sequence shown to mediate binding the c-abl SH3 domain (Ren et al. 1993) .
SWISS-PROT data bases identified no proteins with significant similarity to ena. The most notable feature of the predicted ena protein was a proline-rich core, with 58 proline residues located between amino acids 340--480 and seven matches to the proline-rich consensus site for binding the Abl SH3 domain (Ren et al. 1993; underlined in Fig. 1B ).
ena encodes an SH3-binding protein
The presence of sequences in ena similar to those shown to mediate binding to the c-Abl SH3 domain suggested that ena might also interact with SH3 domains. An ena fusion protein containing amino acids 53-503 of ena was bound by the murine c-Abl and Src SH3 domains ( Fig.  2A) . In contrast, this ena protein was not bound by GST ( Fig. 2A) or by the SH3 domains of Crk, Gap, Nck, or GRB2 (not shown). A fusion protein (amino acids 53-441; Fig. 2B ) lacking the carboxy-terminal three proline motifs from ena was also bound by the c-Abl and Src SH3 domains, whereas ena fusion proteins lacking all seven matches to the SH3 binding consensus (amino acids 53-345 and 53-235) failed to interact with either SH3 domain ( Fig. 2A) . These results indicated that sequences responsible for the interaction with the c-Abl and Src SH3 domains are contained in the proline-rich core of ena.
ena contains phosphotyrosine in vivo
Two ena protein isoforms of -80 and 100 kD were detected in Drosophila $2 cells and pupae (arrows in Fig.  3A , left panel), whereas only the 80-kD form was detected in embryo extracts (Fig. 3A, lanes 2,5) . Both polypeptides were immunoprecipitated by antibodies recognizing two different regions of the ena protein. Neither ena protein was immunoprecipitated with preimmune antisera (not shown). The 100-kD form was less abundant than the 80-kD form and was most readily detected in immunoprecipitates from $2 cells (Fig. 3A) . The 80-kD isoform may correspond to the protein shown in Figure 2, as expression of the eDNA in $2 cells resulted exclusively in the synthesis of the 80-kD isoform (Fig.  4A, lane 2) . Both ena isoforms contained phosphotyrosine, as determined by antiphosphotyrosine Western blots of ena immunoprecipitates (Fig. 3A, right panel) .
Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from (Ren et al. 1993) . The positions of truncations used in the SH3-binding experiments shown in A are indicated relative to these potential SH3-binding sites.
Phosphoamino acid analysis indicated that the 80-kD ena isoform was phosphorylated predominately on serine, with lower levels of threonine and tyrosine phosphorylation (Fig. 3B) .
Although the 100-kD protein was much less abundant than the 80-kD isoform in $2 cells, the two ena isoforms were recognized at similar levels by an antiphosphotyrosine antibody (Fig 3A, right panel, lanes 1, 4) . This observation suggested that the 100-kD form was phosphorylated on tyrosine to a higher stoichiometry than the 80-kD species. The molecular basis for the different mobilities of the two isoforms is not known. Treatment with potato acid phosphatase eliminated antiphosphotyrosine reactivity from the 100-kD isoform but did not alter its mobility (not shown). This suggested that the difference in mobility between the 100-and 80-kD ena polypeptides was not the result of hyperphosphorylation. All of the ena cDNAs recovered thus far correspond to the sequence in Figure 1 ; so if alternatively spliced forms exist, they were not well represented in the embryonic cDNA library used in these experiments. We expect that the 100-kD form is the result of a splicing event that is more prevalent in $2 cells than embryos or pupae. Because the 80-kD ena protein is the most abundant form and this form is able to prevent the lethality caused by ena mutations, we have focused the current study on this ena isoform.
ena is a substrate for Abl
To address whether the phosphotyrosine on ena could be added by the Abl PTK, we examined whether Abl could phosphorylate ena in transfected Drosophila $2 cells. However, an additional test that the phosphorylation of ena by Abl is direct will require mapping and comparing the phosphorylation sites in the in vitro kinase reaction with the ena phosphorylation sites used in vivo. Coexpression of ena and h u m a n c-Abl also resulted in phosphorylation of ena, although at levels below that seen with Drosophila Abl (Fig. 4A, lane 8) . Drosophila Srcl also phosphorylated ena in transfected cells (Fig. 4A , lane 12), although the increased levels of Srcl expression also resulted in the phosphorylation of a number of cellular proteins (Fig. 4B , lane 12).
Several observations suggested that the phosphorylation of ena by Abl was specific. First, the increased expression of Abl after transfection resulted in only a slight increase in phosphotyrosine content of $2 cells (Fig. 4B , lanes 3,4). This indicated that whereas most cellular proteins were not good substrates for Abl, ena was efficiently phosphorylated by Abl. Second, two other molecules that interact genetically with Abl (fax and dab) were not hyperhosphorylated when coexpressed with Abl (data not shown). Finally, coexpression of ena and the Drosophila Fer PTK did not result in increased phosphorylation of ena (Fig. 4A, lane 14) , demonstrating that ,4) , 2-to 16-hr wild-type embryos (lanes 2,5), or wild-type pupae (lanes 3,6) with anti-ena aminoterminal term (lanes 1-3) or anti-ena carboxy-terminal (lanes 4-6) antibodies. Blots were probed with anti-ena amino-terminal (left) or antiphosphotyrosine (right) antibodies. Arrows indicate the positions of 100-and 80-kD ena proteins in the immunoprecipitates. Neither protein was immunoprecipitated with preimmune antisera (not shown). The immunoglobulin heavy chain from the antibody used in the immunoprecipitations is seen in all lanes just above the 49.5-kD marker. (B) Phosphoamino acid analysis of 32P-labeled ena protein from 52 cells shows that ena contains phosphoserine (P-set), phosphothreonine (P-thr), and phosphotyrosine (P-tyr). Hydrolysates of 80-kD ena protein labeled with 32p in vivo were resolved by two-dimensional thin-layer electrophoresis (Cooper et al. 1983 ). The positions of unlabeled phosphoamino acid standards added to the samples and detected with ninhydrin following electrophoresis, as well as 32p-labeled inorganic phosphate (Pi) , are indicated.
ena is not nonspecifically phosphorylated by all nonreceptor tyrosine kinases.
To determine if the interaction between the Abl SH3 
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Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from domain and proline-rich sequences in ena was necessary for phosphorylation of ena, we examined the ability of a c-Abl variant that lacked the SH3 domain to phosphorylate ena. ASH3-c-Abl phosphorylated ena in transfected cells {Fig. 4A, lane 10), indicating that Abl could phosphorylate ena in the absence of an SH3-dependent Ablena interaction. However, ASH3-c-Abl displayed elevated kinase activity that resulted in the promiscuous phosphorylation of numerous cellular proteins [ Fig. 4B,  lanes 9,10) . This observation raised the possibility that the hyperphosphorylation of ena by ASH3-c-Abl was the result of this nonspecific kinase activity.
To test further the hypothesis that the phosphorylation of ena by Abl requires interaction between ena and the Abl SH3 domain, truncations of the ena protein that remove portions of or all of the proline-rich region were assayed for their ability to serve as Abl substrates in $2 cells. Truncated ena proteins containing four, {amino acids 1--440), one (amino acids 1-375), or none {amino acids 1-345) of the matches to the Abl SH3 binding consensus were all hyperphosphorylated when coexpressed with Drosophila Abl but not when expressed alone {Fig. 5, left, lanes 3-8). While full-length ena contained detectable levels of phosphotyrosine in the absence of exogenous kinase (Fig. 5, left, lane 1) , little antiphosphotyrosine reactivity was observed on the ena truncations in the absence of exogenously added Abl (Fig. 5, left, lanes  3,5,7 ). This apparent difference is probably the result of higher expression levels of full-length protein as compared with the truncations (Fig. 5, right, cf. lanes 1,3,5 , and 7). These results indicate that when both the ena substrates and the Abl PTK are overexpressed, an interaction between the Abl SH3 domain and the proline-rich motifs in ena was not required for efficient phosphorylation of ena.
ena tyrosme phosphorylation is reduced in AbI mutants
To determine whether endogenous ena was phosphorylated by Abl during normal development, we compared the state of ena phosphorylation in pupae that were heterozygous or homozygous for Abl mutations. The level of phosphotyrosine on ena was reduced two-to threefold, but not eliminated, in animals that lacked Abl kinase activity as compared with pupae that had one wild-type Abl gene {Fig. 6). Four different combinations of AbI mutations were examined. This reduction in ena phosphorylation was not the result to a global reduction in tyrosine phosphorylation in Abl mutants, as demonstrated by the comparable levels of phosphotyrosine-containing proteins in total lysates from these samples (Fig. 6 , rightl. The observation that ena still contains some phosphotyrosine in Abl mutants indicates that other kinases must also phosphorylate ena in the absence of Abl PTK activity. Although Drosophila Srcl phosphorylated ena in transfected cells {Fig. 4, lane 12), the phosphorylation state of ena was unchanged in Srcl mutant pupae (data not shown). This result indicates that the residual phosphorylation seen on ena from Abl mutant pupae is likely to be the result of phosphorylation by kinases other than Srcl.
Expression of ena during embryogenesis
Polyclonal antibodies to the amino-terminal region of ena were used to examine the temporal and spatial pattern of ena expression during embryogenesis {Fig. 7). No maternal ena protein was detected in unfertilized eggs or early stage embryos (not shown}. Expression of ena protein was first detected during germ-band extension at stage 10 and by stage 11 was detected in the endoderm and ectoderm of the extended germ band [Fig. 7A ). During germ-band retraction, ena protein became restricted to the CNS and by stage 15 was observed primarily in the commissural and longitudinal axons of the CNS {Fig. 7B). During late embryogenesis {stage 17), ena protein was localized primarily to the longitudinal axons {Fig. 7C). No ena expression was observed in ena mutant embryos {Fig. 7D), confirming that these antibodies specifically recognized the ena protein.
CNS and PNS defects in ena mutant embryos
Mutations in ena result in embryonic lethality with no gross developmental abnormalities ). Because of the CNS expression of ena, we sought to determine whether subtle defects in CNS development might exist in ena mutants. Embryos mutant for ena were stained with the monoclonal antibody BP102 to detect the CNS axons. Three different combinations of ena mutant alleles displayed similar CNS axonal defects. The most frequent CNS defect observed in ena mutant embryos was a reduction in the integrity of axon bundles (Fig. 8B) . Whereas the longitudinal and commisural axon tracts of wild-type embryos consist of tightly associated axon bundles (Fig. 8A) , the axons of ena mutants were more diffuse and less tightly bundled (Fig. 8B-D) . In addition, axon misrouting was also observed in 12% of enaGCS/ena cc8 embryos (Fig. 8B) . About one-fourth to one-third of all mutant embryos showed less obvious phenotypes, such as thinning of the longitudinal connectives (arrow in Fig. 8C ), increased numbers of axons exiting the CNS from the longitudinal axons (arrowheads in Fig. 8D ), or the failure of commissural axons to separate into anterior and posterior axon bundles (Fig. 8C) . A cross section through ena mutant nerve cords revealed a defasciculation of BP102-stained axon bundles as compared with a wild-type embryo (Fig. 8, 
cf. E and F).
The monoclonal antibody 22C 10 also revealed defects in the PNS of ena mutant embryos. The PNS of a wildtype embryo consists of regularly spaced neuronal cells connected by stereotypical axon pathways (Fig. 8G) . In ena mutant embryos, the overall organization of the PNS was disrupted (Fig. 8H) . The spacing and organization of the PNS neurons was not as regular as in wild-type, and in some cases clusters of neurons were mislocalized (arrowhead in Fig. 8H ). Finally, some defects in axon guidance were apparent, with axons crossing between PNS elements in adjacent segments (arrow in Fig. 8H ). These defects indicate a role for the ena protein in the organization of the embryonic PNS and CNS.
D i s c u s s i o n
Many proteins are phosphorylated by PTKs, but in general it has been difficult to demonstrate the importance of these substrates in a biological process mediated by the PTK. We have taken a genetic approach in Droso- Figure 7 . Expression of ena protein in wild-type embryos. Wild-type (A-C) or ena mutant embryos (D) were stained with a/-finity-purified anti-ena amino-terminal antibodies as described (Patel et al. 1987 phila to identify proteins on the Abl-mediated pathway by functional criteria, ena was identified by such functional criteria in a genetic screen for dominant secondsite suppresser mutations that alleviate the lethality caused by mutations in the Abl PTK. The ena mutations recovered are loss-of-function mutations that reduce the gene dosage of ena from two functional copies to one copy and presumably reduce the level of active ena protein by 50%. The observation that A b l mutant flies that would usually die as young adult flies or as fully formed adults in the pupal case survive when the level of ena protein is reduced by half suggests that a normal function of Abl is to negatively regulate the activity of ena, presumably by phosphorylation of ena. Furthermore, a balance between the levels of Abl and ena activity appears to be required for normal development, which suggests that Abl and ena have opposite actions on some developmental process.
The best candidate for this developmental process is the formation of axonal connections in the nervous system. In the embryo, both proteins are expressed at highest levels in the axons of the developing nervous system and mutations in both genes are associated with defects in the embryonic axonal architecture. Abl's role in axonal development has been revealed by removing functionally redundant genes such as fasciclin I. The role of fasciclin I as a cell-adhesion molecule and the defects in axonal pathfinding in Abl, fas I m u t a n t embryos has implicated Abl in the regulation of axonal cell adhesion (Elkins et al. 1990 ). The importance of Abl kinase activity in development is also masked by the functions of the genes dab, pros, and fax. When this functional redundancy is eliminated by mutations in these genes, development of the axonal architecture of the nervous system is disrupted, revealing a role for Abl in this process. In embryos mutant for both A b l and dab, there is a general failure to form axon bundles in the embryonic CNS (Gertler et al. 1989 (Gertler et al. , 1993 . Normal axonal connections are largely restored by kinase-active Abl or by a reduced level of ena, whereas kinase-defective Abl protein has no detectable effect. Therefore, reduced levels of ena can have effects similar to addition of kinase-active Abl in a background with mutations in both Abl and dab. The Abl PTK in Drosophila also has a structural function that is independent of kinase activity. We have reported previously that the Abl mutant lethality is rescued by a kinase-defective form of the Abl protein in which the invariant lysine in the catalytic domain is mutated to asparagine (Henkemeyer et al. 1990 ). This kinase-independent structural role of Abl requires proper subcellular localization to the axons of the developing CNS, and sequences in the domain carboxy-terminal to the kinase domain are necessary for this localization. Reduction in the level of ena compensates for the absence of this proposed structural role of Abl by rescuing the Abl mutant lethality as effectively as the presence of the kinase-defective protein.
To understand the molecular mechanisms by which ena interacts with the Abl signaling pathways, we have characterized the ena protein and discovered two interesting properties--binding to SH3 domains and phosphorylation by the Abl PTK. The binding of the Abl SH3 domain to ena suggests several models for ena function. One model to explain the opposing actions of Abl and ena would have ena as a negative regulator of Abl and other PTKs that are functionally redundant to Abl. Reducing ena would allow more kinase activity from the redundant PTKs and compensate for the absence of Abl kinase activity. The presence of the proline motifs in ena provides a molecular mechanism by which ena could act as a negative regulator, that is, by binding to the SH3 domain of the redundant kinases. Negative regulation of the c-Abl PTK has been proposed to be mediated by interactions between the c-Abl SH3 domain and an unidentified cellular factor (Pendergast et al. 1991) . Although ena can bind to the murine Abl and Src SH3 domains in vitro, we have no evidence that the presence of ena reduces Abl or c-Abl kinase activity as indicated by Abl or c-Abl autophosphorylation in $2 cells (data not shown). Because of its inability to affect Abl autophosphorylation, ena is unlikely to be the Drosophila homolog of the proposed negative inhibitor of mammalian c-Abl. Although ena protein did reduce the level of enolase phosphorylation by Abl in vitro, this effect may be the result of simple competitive inhibition by a better substrate. The possibility remains, however, that ena may negatively regulate in vivo another SH3-containing kinase that is functionally redundant to Abl.
SH3 domain-dependent interactions are important in the recruitment of some tyrosine kinase substrates. For example, the binding of the SH3 domain of crk to proline-rich sequences in c-Abl facilitates phosphorylation of crk (Feller et al. 1994; Ren et al. 1994 ). The SH3 domain of Src also appears to be required for efficient phosphorylation of a subset of Src substrates (Weng et al. 1994) . We considered the possibility that the proline motifs on ena might function to bind to the Abl SH3 domain to present ena for phosphorylation. However, we observed that truncated ena proteins lacking most or all of the proline-rich region were still phosphorylated by Abl when overexpressed in transfected cells. In addition, we have not detected association between Abl and ena in immunoprecipitates of either protein. However, other SH3 domain-binding interactions have not allowed coimmunprecipitation of the two proteins; for example, although proline-rich motifs in Btk mediate an interaction with the Fyn SH3 domain in vitro and in the yeast two-hybrid system, this interaction was not detected by coimmunoprecipitation from cells expressing both proteins (Cheng et al. 1994) . If Abl and ena do associate in Drosophila, the interaction may be too transient or the affinity too low to survive immunoprecipitation.
The second property of ena reported here, its phosphorylation by Abl, suggests alternative models for ena function. An obvious role for the phosphorylation of ena is to provide sites through which ena can interact with specific SH2 domains. In this model, ena would function as an adapter molecule and the interaction of ena with SH2 domain-containing proteins would be regulated by phosphorylation of ena by Abl and other PTKs. There may be multiple sites of tyrosine phosphorylation on ena because, in Abl mutant animals, the level of phosphotyrosine on ena was reduced but not eliminated. This is consistent with the existence of at least one other PTK capable of phosphorylating ena. It will be important to determine whether there are specific tyrosine phosphorylation sites on enabled at which the level of phosphorylation is reduced in Abl mutant animals and to determine whether these are the same residues phosphorylated by Abl in vitro. Different sites of phosphorylation could provide ena with the ability to interact with different SH2 domains. We think it unlikely that the SH2 domain of Abl interacts with phosphorylated ena, as none of the tyrosines in ena lie within sequences similar to those bound by the Abl SH2 domain (Songyang et al. 1993) . By binding to ena, SH2-containing proteins would be brought into proximity to the SH3 domain-containing proteins bound to the ena proline motifs. The multiple proline-rich motifs in ena could provide separate sites for binding different SH3 domains or could enhance SH3-domain binding by providing a high local concentration of proline-rich motifs. The binding of ena to SH2-and/or SH3-containing proteins could facilitate the assembly of signaling complexes involved in axon outgrowth or pathfinding.
Binding of ena to SH3 domain-containing proteins could be important for the subcellular distribution of ena, as SH3 domains are known to direct the subcellular localization of signaling molecules (Bar-Sagi et al. 1993) . The subcellular localization of the Abl PTK is important for its function in Drosophila axonogenesis (Henkemeyer et al. 1990) , and it is likely that subcellular localization of ena is also important for its interactions with Abl. Interactions involving SH3 domains are also important in subcellular localization and protein-complex assembly during signal transduction. For example, association of proline-rich sequences in Sos with the SH3 domains of Drk (the Drosophila homolog of GRB2) brings
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The observation that the state of occupancy of adjacent SH2 or SH3 domains can affect ligand binding of the other domain (Panchamoorthy et al. 1994 ) suggests a third model in which Abl-phosphorylated ena would associate with different SH3-SH2-containing proteins than unphosphorylated ena. ena's interactions with these target proteins could regulate their activity. For example, the GTPase activity of dynamin is activated when dynamin is bound by the SH3 domains of Grb2, Src, Fgr, and Fyn (Gout et al. 1993) . In addition, PI-3 kinase displays elevated catalytic activity when bound to the SH3 domains of Lyn or Fyn (Pleiman et al. 1994) .
The models of ena as an adapter molecule or regulator must take into account the genetic interactions between Abl and ena. Because reduced levels of ena compensate for the absence of Abl, we propose that Abl phosphorylation of ena would provide a negative regulatory effect on ena function. For example, if ena protein stimulates the activity of an enzyme, Abl phosphorylation of ena would reduce the ability of ena to bind to and activate that enzyme. The absence of Abl would lead to hyperactivation of the enzyme by unphosphorylated or underphosphorylated ena; reduction in the level of ena protein might compensate and restore a normal level of enzyme activity. Therefore, it may be more accurate to consider the effect of AbI mutations as leading to a hypophosphorylation of ena tyrosines rather than the complete elimination of ena phosphorylation.
We propose that interactions between ena and other unidentified proteins are involved in the dynamic processes of cell adhesion and/or cytoskeletal changes required for optimal axonal outgrowth or fasciculation. The identification of SH3 domain-and SH2 domain-contaming proteins other than Abl that bind to ena during neural development in Drosophila is a goal of ongoing experiments. Further analysis of ena function and its molecular mechanisms of action in Drosophila should provide additional insights into the cell biology of axonal outgrowth, pathfinding, and fasciculation.
The identification of ena as a biologically important substrate of the Drosophila Abl PTK raises the possibility that a similar protein exists in mammals. A murine gene encoding a protein closely related to ena has recently been identified (F.B. Gertler, P. Soriano, and F.M. Hoffmann, unpubl.) . Analysis of this murine protein to determine whether it is the mammalian counterpart of ena and to ascertain whether it interacts biochemically or functionally with the mammalian c-Abl PTK could provide new information about processes that are regulated by c-Abl and that are perturbed by oncogenically activated Abl proteins in mammalian systems.
Materials and methods
v-ray mutagenesis and cytological mapping of ena alleles
Isogenic adh pr cn males were irradiated with 4500 rads and crossed en masse to Sp/CyO; TM2 Ubx/TM6B, Tb virgin females for 2 days. Individual Cy male progeny were crossed to two ena21~ virgin females. Fertile crosses were scored for absence or reduction of the CyO + progeny class and stocks were established of putative new ena alleles. Males bearing the new ena mutations were mated to w m f virgins at 18~ Spreads of polytene chromosomes stained with orecien were prepared as described (Ashburner 1989 
Molecular isolation and sequencing of ena
Genomic DNA from the AA48 P-element stock (gift of T. Laverty and G.M. Rubin, University of California, Berkeley) was cut with PstI and used for plasmid rescue. A 7-kb PstI restriction fragment was used to initiate the walk in a cosmid library (gift of Dr. J. Tamkun, University of California, Santa Cruz). A 12-to 24-hr embryonic cDNA library (Brown and Kafatos 1988) was screened with a 5.5-kb EcoRI fragment (fragment A from Fig. 1 ). Four independent but related cDNAs were purified in the screen. Templates were sequenced with [35S]dATP using the Sequenase 2.0 system (U.S. Biochemical). The sequences were compiled and edited using the MacVector and Assemblyalign programs (IBI). Other sequence analyses were conducted using the Genetics Computer Group software. All sequences presented were confirmed by sequencing the reverse strand. Data bases were searched using the FASTA program.
Fusion proteins and SH3-binding assays
pHisena sa-s~ was produced by ligating a 1.3-kb PstI fragment of ena (bases 568-1909) into the PstI site of pQE31 (Qiagen). pHisena s3--441, pHisena 53--345, and pHisena s3-235 were generated by first digesting pHisena 53-5~ with HindlII, which is present in the pQE31 polylinker 3' to the PstI site, and then with NcoI (441), Saul (345), or NaeI (235). For GST fusions, cultures were lysed in a nitrogen cell disruption chamber and the proteins bound to glutathione-Sepharose (Pharmacia) essentially as described (Smith and Johnson 1988) . For His-tagged proteins, cultures were lysed in 6 M guanidine-HC1 and fusion proteins purified by affinity to Ni-NTA agarose (Qiagen) as recommended the manufacturer.
For in vitro SH3 binding experiments, fusion proteins were fractionated on 10% SDS-PAGE gels and transferred to nitrocellulose as described (Harlow and Lane 1988) . The binding assays were conducted as described (Olivier et al. 1993) .
Generation and purification of ena antibodies
DNA fragments encoding amino acids 55-235 {ena amino-terminal) and 491--684 {ena carboxy-terminal) were subcloned into the pQE-30 and pQE-32 expression vectors {Qiagen) to generate ena fusion proteins preceded by 6 histidine residues. Fusion proteins were induced and purified from bacterial lysates by chromatography on nickel affinity columns as recommended by the manufacturer. Rabbits were immunized with 250 lxg of amino-or carboxy-terminal fusion proteins and boosted every 4 weeks with 250 ~g of antigen. Specific antibodies were purified from immune serum by affinity chromatography over immobilized antigen columns as described (Robbins et al. 1984) .
Immunoprecipitations and Western blot analysis
For immunoprecipitations, $2 cells were lysed at 1 x 107cells/ml in IP buffer [0.5% NP-40, 150 mM NaC1, 50 mM Tris-C1 (pH 8.0), 5 m/vIEDTA] containing 1 mM NasVO4, 1 rnM Pefabloc (Boehringer Mannheim), and 1 ~g/ml each of aprotinin, leupeptin, and aprotinin. For immunoprecipitations from pupae or embryos, 20 pupae or -0.05 ml of embryos were homogenized in 1 ml of IP buffer containing 0.1% SDS. Samples were lysed on ice for 30 min, cell debris was pelleted for 20 min at 4~ in a microcentrifuge, and lysates were precleared with preimmune Ig for 45 min at 4~ For ena or Abl immunoprecipitations, lysates were incubated with 2.5 ~g of specific antibody for 4 hr at 4~ Immune complexes were collected with protein A (Pierce)-agarose, washed three times with IP buffer, and boiled in SDS sample buffer (Laemmli 1970) . Immunoprecipitates were resolved on 7.5% SDS-polyacrylamide gels and transferred to PVDF membranes (Immobilon-P, Millipore Corporation) in 10 mM CHES (pH 9.6), 10% ethanol. Filters were blocked with 5% BSA in TBST [50 mM Tris-C1 (pH 8.0), 150 mM NaC1, 0.05% Tween 20]. For ena Western blots, filters were incubated with primary antibody at 0.5 ~g/ml, washed with TBST, then incubated with HRP-conjugated secondary antibodies and developed by ECL {Amersham). Western blots with Abl antibodies were performed as above, except the Ig concentration was 0.15 ~g/ml. Phosphotyrosine was detected using monoclonal antibody 4G10 (Upstate Biotechnology) at 1 ~g/ml. For quantitative Western analysis, samples were serially diluted to determine a linear range for densitometry.
Immune-complex kinase assays
Immunoprecipitates were prepared as described above except that immune complexes were washed twice with IP buffer and once with kinase buffer [20 mM PIPES (pH 6.9), 10 mM MgC12, 10 mM MnC12, 1 mM DTT, 1 ~M ATP]. Samples were then suspended in 20 t~1 of kinase buffer containing 10 ~Ci [TS2P]ATP and 5 ~g of acid-denatured enolase. Bacterially produced ena protein (amino acids 53-503) was eluted from Ni-NTA beads in 0.5 M imidazole, and supematants containing 5 ~g of ena protein were added to the kinase reactions, which were then incubated at 30 ~ for 1 hr. Samples were resolved on 7.5% SDS gels, the gels were fixed, Coomassie stained, and dried, and phosphorylated proteins were detected by autoradiography.
Phosphoamino acid analysis
Drosophila $2 cells (5 x 107) labeled with carrier-free [32p]orthophosphate (ICN) were harvested and 32p-labeled ena protein was immunoprecipitated as described above. Immunoprecipitates were resolved on SDS-PAGE and transferred to an Immobilon-P membrane. The 32p-labeled ena protein band was excised and hydrolyzed by incubation in 6 M HC1 at 110~ for 1 hr. Hydrolysates were lyophilized and suspended in 10 ~1 of water containing lmg/ml of phosphoserine, phosphothreonine, and phosphotyrosine standards (Calbiochem). The samples were applied to 0.1-mm-thick cellulose plates, resolved by two-dimensional thin-layer electrophoresis {Cooper et al. 1983) , and stained with ninhydrin, and the labeled phosphoamino acids were detected by autoradiography.
HRP immunocytochemistry and sectioning of immunostained embryos
Canton-S embryos staged from 0 to 18 hr were fixed and stained for antibody against ena using modifications of published procedures (Patel et al. 1987) . Rabbit anti-ena polyclonal antibody was used to detect ena. Mouse monoclonal anti-~-galactosidase (Promega) antibody was used to detect lacZ expression from enhancer-trap-containing balancer chromosomes to distinguish ena null embryos from their sibs having ena + balancer chromosomes, ena mutant embryos were generated from crosses of enaCCl/CyolacZ or enaCCS/CyolacZ to enaaCS/CyolacZ. BP102 was used to detect the CNS axons. After staining with Streptavidin-horseradish peroxidase, some enaCCl/ena cc8 embryos were embedded in LR White. Cross sections of 6 ~m were cut and mounted on glass slides.
